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ABSTRACT 
The side effects and drug resistance are two limits in the application of chemotherapeutic 
drugs. All-trans retinoic acid, ATRA as a natural compound may help to overcome these 
limitations. To assess this hypothesis, we investigated the efficacy of combined treatment by 
chemotherapeutic drugs and ATRA on different cancer cell lines and stem cells using different 
methods including cell viability, cell apoptosis, cell cycle analysis, RT-PCR, and ELISA. 
Results showed that the combination therapy increases the effectiveness of chemotherapeutic 
drugs in terms of increasing the expression of the proteins leading to apoptosis and arresting 
the cells in G1. In conclusion, ATRA has synergistic effects with chemotherapy leading to 
usage of low dosages of drugs, especially in stem cells. Low doses of drugs in combination 
with ATRA promise new opportunities in cancer treatment without worrying much about 
chemotherapy side effects and drug resistance. 
Keywords: ATRA, Cancer, Chemotherapy, cell line 
  
